跳至主要内容
临床试验/IRCT2015042021875N1
IRCT2015042021875N1已完成未知

Comparison of efficacy and side effects of Latanoprost versus Timolol on decreasing IOP in patients with glaucoma

Vice chancellor for research and technology of Islamic Azad University of Shahrood0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Presence of open angle glaucoma symptoms; ocular hypertension includes patients with increased IOP; glaucomatous cupping (cup to disc ratio between 0.4 - 0.7; disc-cup asymmetry>0.2; notching of the rim; enlargement of the cup; bleeding of the rim of the disc; degeneration of the nerve fiber layer)
  • Exclusion criteria:
  • Secondary causes of increasing IOP; cup to disc ratio>0.7; IOP>30 mmHg in each stage of the disease; existing of any other ocular disorder except glaucoma; corrected vision less than 20/50; bradycardia; asthma; COPD; consumption of any drug affecting IOP for example beta blockers, corticosteroids, carbonic anhydrase inhibitors, nitrates and alpha 2 agonists; discontent of patient.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research and technology of Islamic Azad University of Shahrood

相似试验

Comparison of efficacy of two ophthalmic drops on... | 临床试验